{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T02:02:53Z","timestamp":1765591373022,"version":"3.48.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"DOI":"10.7759\/cureus.99072","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T01:58:59Z","timestamp":1765591139000},"source":"Crossref","is-referenced-by-count":0,"title":["Estrogen Receptor-Low Breast Cancer With Sternal Metastasis Presenting as \u201cStiff Neck\u201d in a Young Female"],"prefix":"10.7759","author":[{"given":"Hinata","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Mine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam A","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Kutomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison KH","year":"2020","unstructured":"Allison KH, Hammond ME, Dowsett M, et al.. Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update. J Clin Oncol. 2020, 38:1346-66. 10.1200\/JCO.19.02309","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1015388","article-title":"Clinical implication of low estrogen receptor (ER-low) expression in breast cancer","volume":"13","author":"Reinert T","year":"2022","unstructured":"Reinert T, Cascelli F, de Resende CA, Gon\u00e7alves AC, Godo VS, Barrios CH. Clinical implication of low estrogen receptor (ER-low) expression in breast cancer. Front Endocrinol (Lausanne). 2022, 13:1015388. 10.3389\/fendo.2022.1015388","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2023.1182488","article-title":"Pain associated with breast cancer: etiologies and therapies","volume":"4","author":"Doan LV","year":"2023","unstructured":"Doan LV, Yoon J, Chun J, Perez R, Wang J. Pain associated with breast cancer: etiologies and therapies. Front Pain Res (Lausanne). 2023, 4:1182488. 10.3389\/fpain.2023.1182488","journal-title":"Front Pain Res (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman GD","year":"2004","unstructured":"Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004, 350:1655-64. 10.1056\/NEJMra030831","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE- 355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes J","year":"2020","unstructured":"Cortes J, Cescon DW, Rugo HS, et al.. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE- 355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial. Lancet. 2020, 396:1817-1828. 10.1016\/S0140-6736(20)32531-9","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100114","article-title":"Evolution of overall survival and receipt of new therapies by subtype among 20\u2009446 metastatic breast cancer patients in the 2008-2017 ESME cohort","volume":"6","author":"Grinda T","year":"2021","unstructured":"Grinda T, Antoine A, Jacot W, et al.. Evolution of overall survival and receipt of new therapies by subtype among 20\u2009446 metastatic breast cancer patients in the 2008-2017 ESME cohort. ESMO Open. 2021, 6:100114. 10.1016\/j.esmoop.2021.100114","journal-title":"ESMO Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2014.17.4.301","article-title":"Unique features of young age breast cancer and its management","volume":"17","author":"Lee HB","year":"2014","unstructured":"Lee HB, Han W. Unique features of young age breast cancer and its management. J Breast Cancer. 2014, 17:301-7. 10.4048\/jbc.2014.17.4.301","journal-title":"J Breast Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00543-0","article-title":"Immune landscape of breast tumors with low and intermediate estrogen receptor expression","volume":"9","author":"Voorwerk L","year":"2023","unstructured":"Voorwerk L, Sanders J, Keusters MS, et al.. Immune landscape of breast tumors with low and intermediate estrogen receptor expression. NPJ Breast Cancer. 2023, 9:39. 10.1038\/s41523-023-00543-0","journal-title":"NPJ Breast Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100896","article-title":"Into the twilight zone - should ER-low breast cancer be treated as triple negative breast cancer?","volume":"40","author":"Jernstr\u00f6m H","year":"2024","unstructured":"Jernstr\u00f6m H, Ryd\u00e9n L. Into the twilight zone - should ER-low breast cancer be treated as triple negative breast cancer?. Lancet Reg Health Eur. 2024, 40:100896. 10.1016\/j.lanepe.2024.100896","journal-title":"Lancet Reg Health Eur"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology breast cancer survivorship care guideline","volume":"34","author":"Runowicz CD","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, et al.. American Cancer Society\/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016, 34:611-35. 10.1200\/JCO.2015.64.3809","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2017.04.010","article-title":"Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis","volume":"48","author":"Koo MM","year":"2017","unstructured":"Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis. Cancer Epidemiol. 2017, 48:140-6. 10.1016\/j.canep.2017.04.010","journal-title":"Cancer Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/014107689208500409","article-title":"'I thought it would go away': patient denial in breast cancer","volume":"85","author":"Phelan M","year":"1992","unstructured":"Phelan M, Dobbs J, David AS. 'I thought it would go away': patient denial in breast cancer. J R Soc Med. 1992, 85:206-7. 10.1177\/014107689208500409","journal-title":"J R Soc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.0990","article-title":"Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors","volume":"82","author":"Nosarti C","year":"2000","unstructured":"Nosarti C, Crayford T, Roberts JV, Elias E, McKenzie K, David AS. Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors. Br J Cancer. 2000, 82:742-8. 10.1054\/bjoc.1999.0990","journal-title":"Br J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.109-5705","article-title":"Why do patients often lie to their doctors?","volume":"191","author":"Vogel L","year":"2019","unstructured":"Vogel L. Why do patients often lie to their doctors?. CMAJ. 2019, 191:E115. 10.1503\/cmaj.109-5705","journal-title":"CMAJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0277-9536(93)90340-A","article-title":"Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay","volume":"36","author":"Facione NC","year":"1993","unstructured":"Facione NC. Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med. 1993, 36:1521-34. 10.1016\/0277-9536(93)90340-A","journal-title":"Soc Sci Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/411506-estrogen-receptor-low-breast-cancer-with-sternal-metastasis-presenting-as-stiff-neck-in-a-young-female","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T01:59:00Z","timestamp":1765591140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/411506-estrogen-receptor-low-breast-cancer-with-sternal-metastasis-presenting-as-stiff-neck-in-a-young-female"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.99072","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}